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Abstract 
Given the widespread occurrence of azaspiracids (AZAs) it is clearly necessary to advance in 
simple and low-cost methods for the rapid detection of these marine toxins in order to protect 
seafood consumers. To address this need, electrochemical immunosensors for the detection of 
AZAs based on a competitive direct immunoassay using peroxidase-labelled AZA as a tracer were 
developed. An anti-AZA polyclonal antibody was immobilised in a controlled and stable manner 
on protein G or avidin-coated electrodes. Experimental conditions were first optimised using 
colorimetric immunoassays on microtitre plates, providing intermediate products already 
applicable to the accurate detection of AZAs. Then, transfer of the protein G and avidin–biotin 
interaction-based immunoassays to 8-electrode arrays provided compact and miniaturised 
devices for the high-throughput detection of AZAs. The low amounts of immunoreagents 
required as well as the potential for reusability of the avidin–biotin interaction-based 
immunosensors represented significant economic savings as well as a contribution to 
sustainability. The electrochemical immunosensors enabled the quantification of all regulated 
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AZAs below the regulatory limit, as well as a broad range of other toxic AZA analogues (from 63 
± 3 to 2841 ± 247 µg AZA-1 equiv./kg for the protein G-based immunosensor and from 46 ± 2 to 
3079 ± 358 µg AZA-1 equiv./kg for the avidin–biotin interaction-based immunosensor). The good 
agreement between the results obtained by the immunosensors and LC-MS/MS in the analysis 
of naturally contaminated mussel samples demonstrated the easy implementation of 
electrochemical immunosensors for routine analysis of AZAs in food safety monitoring 
programs. 
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1. INTRODUCTION 
Harmful algal blooms (HABs) and their associated marine toxins pose a serious threat to human 
health and are an economic concern for the shellfish industry. Among many different groups of 
marine toxins of microalgal origin are azaspiracids (AZAs). AZAs were first identified in 1998 from 
contaminated mussels from Ireland that had caused a poisoning outbreak in The Netherlands in 
the mid-1990s [1]. Since then, AZAs have been particularly problematic in Ireland, but they have 
also been reported in phytoplankton and/or shellfish around the world including the US [2], 
China [3], Japan [4], Chile [5, 6] and Argentina [7]. In Europe, AZAs have been found in several 
countries adjacent to the North Sea such as Norway, Denmark, UK and Sweden [8-10]. AZAs 
have also been found in the Atlantic coast of other European countries including France, 
Portugal and Spain [11-15], in the Atlantic coast of NW Africa [16], as well as in countries of the 
Mediterranean Sea [17].  
The AZA group includes more than 40 analogues, which are either produced by phytoplankton 
of the genera Azadinium and Amphidoma, through biotransformation in shellfish, or as by-
products resulting from storage or cooking of AZA-contaminated shellfish [18]. However, only 
AZA-1–3 are currently regulated by the European Commission, with 160 µg AZA-1 equivalents/kg 
being the maximum permitted level in shellfish meat [19]. 
Although current reference chemical methods are highly specific and sensitive, they require the 
use of sophisticated equipment and trained personnel, being expensive and relatively slow to 
perform. Thus, there is a need for easy-to-use, rapid, inexpensive and accurate devices for the 
detection of AZAs in shellfish in monitoring programs. Biosensors have the potential to address 
this need and, among them, electrochemical biosensors stand out for several reasons: their 
inherently high sensitivities, low cost, possibility for miniaturisation of electrodes and 
potentiostats, compatibility with microfluidics systems and automation and subsequent 
simplification of the protocols [20]. Likewise, the high specificity and selectivity of antibodies 
(Abs) positions immunosensors as highly attractive candidates for the rapid screening of marine 
toxins. 
Nonetheless, the lack of commercially available anti-AZA Abs has hindered the development of 
immunosensors, as well as immunoassays, for the detection of AZAs. To date, only a monoclonal 
antibody (MAb) raised using AZA-1 [21] and a polyclonal antibody (PAb) raised using a synthetic 
fragment of AZA [22] have been reported. While the MAb was used in the development of a 
flow fluorimetry-based immunoassay [23], the anti-AZA PAb has been used in the development 
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of an enzyme-linked immunosorbent assay (ELISA) [24] and an electrochemical immunoassay 
using magnetic beads as immunorecognition supports [25].  
Another crucial step in the development of immunoassays and immunosensors is the 
immobilisation of the Ab on a solid support. To achieve full functionality, the conformation of 
the Abs should not be altered and their binding sites should remain accessible after 
immobilisation. Moreover, in the development of electrochemical biosensors, the 
immobilisation procedure should ensure a close proximity between the label and the transducer 
in order to obtain an efficient electron transfer. Bioaffinity immobilisation, mainly based on the 
avidin–biotin interaction and the affinity of protein A/G for immunoglobulins (IgGs), provides an 
attractive method for the controlled and stable surface-tethering of antibodies. In our previous 
work [25], the anti-AZA PAb was immobilised on protein G-coated magnetic beads and a 
competitive step using peroxidase-labelled AZA (AZA–HRP) was performed. The use of magnetic 
beads facilitated performance of the assay in suspension, thus allowing rapid assay kinetics, but 
mass transfer limitations were observed when the immunocomplexes were subsequently 
anchored on the electrode surface to perform electrochemical detection. In the present work, 
the anti-AZA PAb is immobilised on the electrode surface by means of protein G, or, 
alternatively, through the avidin–biotin interaction, with the aim of overcoming the drawbacks 
associated with the packed distribution of magnetic beads on the electrode surface and allowing 
a controlled and homogenous immobilisation of the antibody directly on the transducer surface. 
The immobilisation of the Ab directly on the transducer surface provides more compact and 
automated devices, since all reactions are performed on the electrode array, with possible signal 
enhancement since the enzyme product is concentrated closer to the transducer surface. 
Colorimetric immunoassays were first developed on microtitre plates and used for protocol 
optimisation and assay characterisation. Their suitability for AZAs screening and quantification 
in mussels was also demonstrated. Protein G and avidin–biotin interaction-based immunoassays 
were then transferred to electrode arrays to develop the corresponding competitive 
electrochemical immunosensors. With the aim of further improving the economic saving 
represented by the use of the immunosensors, their reusability was explored. The 
immunosensors were applied to the determination of AZAs in a mussel certified reference 
material (CRM) and in mussel samples obtained from the Irish monitoring program. To the best 
of our knowledge, this work describes the first immunosensors for AZAs detection and 
guarantees their implementation in routine monitoring programs.  
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2. MATERIALS AND METHODS 
 
2.1. Reagents and solutions 
Protein G from Streptococcus sp., avidin from egg white, sodium carbonate, sodium bicarbonate, 
potassium phosphate monobasic, potassium chloride, Tween–20, bovine serum albumin (BSA) 
and 3,3’-5,5’-tetramethylbenzidine (TMB) liquid substrate were purchased from Sigma–Aldrich 
(Madrid, Spain). Milli-Q water (Millipore, Bedford, USA) was used to prepare solutions. 
Certified reference materials (CRMs) of AZA-1−3, Zero-Mus and AZA-Mus were obtained from 
the National Research Council of Canada (NRC, Halifax, NS, Canada). Reference materials (RMs) 
of AZA-4–10 were prepared as described by Kilcoyne et al. [26]. 
HRP (Type VI-A) from Sigma–Aldrich (Oslo, Norway) was conjugated to purified AZA-1 [27] using 
standard procedures for covalent linking of small molecules to enzymes [28]. Antiserum AgR367-
11b (anti-AZA PAb) was obtained after 11 immunisations with two different haptens as 
described in Samdal et al. [24]. 
Biotin labelling of the anti-AZA PAb was performed with EZ-LinkTM NHS–PEG4–Biotin from 
Thermo Fisher (Barcelona, Spain) following the manufacturer’s manual. Unreacted NHS–PEG4–
Biotin was removed by Zeba Spin Desalting Colums (7 kDa MWCO, 2 mL) from Thermo Fisher. 
 
2.2. Equipment 
Colorimetric measurements were performed with a Microplate Reader KC4 from BIO-TEK 
Instruments, Inc. (Winooski, VT, USA). Gen5 software was used to collect and evaluate data. 
An array of eight screen-printed carbon electrodes (DRP-8X110) and a boxed connector (DRP-
CAST8X) were provided by Dropsens S.L. (Oviedo, Spain). The array consists of 8 carbon working 
electrodes of 2.5 mm in diameter, each with its own carbon counter electrode and silver 
reference electrode. Amperometric measurements were performed with a PalmSens 
potentiostat connected to an 8-channel multiplexer (MUX8) (Houte, The Netherlands). Data 
were collected and evaluated with PalmSens PC software. 
 
2.3. Raw and heat-treated mussel tissues 
AZA-Mus CRM (NRC, Halifax, NS, Canada) prepared from naturally contaminated mussel (Mytilus 
edulis) tissues and AZA-contaminated raw mussel samples (M. edulis) from the routine 
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monitoring program in Ireland, were selected for analysis. Zero-Mus CRM (M. edulis) (NRC, 
Halifax, NS, Canada) was used to evaluate matrix effects. 
Mussels were shucked and homogenised with an Ultra Turrax homogenizer. A three-step 
extraction with MeOH (10 mL) was performed on AZA-Mus and Zero-Mus homogenised tissues 
(1 g) according to Gerssen et al. [29], using a protocol that was intra-laboratory validated by 
García-Altares et al. [30]. A vortex-mixer MS2 Minishaker (IKA Labortechnik, Staufen, Germany) 
and a centrifuge Jouan MR 23i (Thermo Fisher Scientific Inc., Waltham, MA, USA) were used. 
Crude extracts were filtered through polytetrafluoroethylene (PTFE) 0.2-μm membrane syringe 
filters. Thus, AZA-Mus and Zero-Mus extracts at a matrix concentration of 100 mg/mL were 
obtained.  
Extraction of the Irish AZA-contaminated raw mussel samples was performed by a two-step 
extraction with MeOH (25 mL) as follows.  Homogenised tissue samples were weighed (2 g) into 
50-mL centrifuge tubes and extracted by vortex mixing for 1 min with 9 mL of MeOH, centrifuged 
at 3950 g (5 min), and the supernatants decanted into 25-mL volumetric flasks. The pellets were 
further extracted using an Ultra Turrax for 1 min with an additional 9 mL of MeOH, centrifuged 
at 3950 g (5 min), and the supernatants decanted into the same 25-mL volumetric flasks, which 
were brought to volume with MeOH. A portion (10 mL) of each extract was transferred into 
sealed centrifuge tubes and placed for 10 min in a water bath heated to 90 °C to decarboxylate 
carboxylated AZAs [31, 32]. The raw and heat-treated samples were then passed through 
Whatman 0.2-µm cellulose acetate filters into HPLC vials for analysis. Heated and raw mussel 
extracts were obtained at a matrix concentration of 80 mg/mL. All samples were stored at -20 
°C until analysis. 
 
2.4. Colorimetric immunoassays protocol 
Colorimetric immunoassays were carried out on 96-well microtitre plates. Microtitre wells were 
incubated with 50 µL of 10 µg/mL protein G or 1 µg/mL avidin in 0.1 M carbonate buffer, pH 9.6, 
for 1 h. The anti-AZA PAb or biotinylated PAb was then immobilised on the protein G or avidin-
coated plates, respectively, by the addition of 50 µL of the corresponding antibody dilution (from 
1/10000 to 1/80000 for protocol optimisation and 1/40000 for the final competition assay) in 
PBS–Tween (0.1 M PBS, pH 7.2, with 0.05% v/v Tween–20) for 1 h. Blocking was then carried out 
using 100 µL of PBS–Tween containing 2% w/v BSA for 1 h. Subsequently, the competition step 
was performed using 25 µL of AZA-1 standard solutions (from 0.20 µg/L to 100 µg/L) or natural 
samples at different dilutions in PBS–Tween and 25 µL of different dilutions of AZA–HRP (from 
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1/800 to 1/3200 for protocol optimisation and 1/1600 for the final competition assay) for 30 
min. Finally, 100 µL of TMB liquid substrate was added, and 10 min later the absorbance was 
read at 620 nm. After each step, wells were rinsed three times with 100 µL PBS–Tween. During 
incubations, microtitre plates were placed on a plate shaker. All reactions were carried out at 
room temperature. 
 
2.5. Electrochemical immunosensors protocol 
The immunosensor assay protocols were essentially the same as the colorimetric immunoassays 
except for adjustments to the volumes for 8-electrode arrays and diffences in the detection step. 
Volumes of 10 µL were applied to each working electrode (5 µL of standard or sample dilution 
plus 5 µL of AZA–HRP in the competition step), and the blocking step was performed by 
immersion of the electrode arrays in PBS–Tween containing 2% w/v BSA. To perform the 
electrochemical measurement, 10 µL of TMB was added to each electrode and incubated for 10 
min and, finally, the TMB reduction current was measured by applying –0.2 V vs. Ag for 0.5 s. 
After each step, the electrode arrays were rinsed with PBS–Tween and dried. All reactions were 
carried out at room temperature.  
For the regeneration of the electrochemical immunosensors, the electrode arrays were rinsed 
with PBS–Tween after the electrochemical measurement and immersed in glycine buffer, pH 
2.7, for 30 min. The immunosensors were then rinsed again with PBS–Tween and stored at 4 °C 
until use. 
 
2.6. LC-MS/MS analysis 
For LC-MS/MS analysis of AZA analogues, a Waters Acquity UPLC coupled to a Xevo G2-S QToF 
monitoring in MSe mode (m/z 100−1200) was used with leucine enkephalin as the reference 
compound. The cone voltage was 40 V, collision energy was 50 V, the cone and desolvation gas 
flows were set at 100 and 1000 L/h, respectively, and the source temperature was 120 °C. 
Analytical separation was performed on an Acquity UPLC BEH C18 (50 × 2.1 mm, 1.7 µm) column 
(Waters). Binary gradient elution was used, with phase A consisting of H2O and phase B of CH3CN 
(95%) in H2O (both containing 2 mM ammonium formate and 50 mM formic acid). The gradient 
was from 30–90% B over 5 min at 0.3 mL/min, held for 0.5 min, and returned to the initial 
conditions and held for 1 min to equilibrate the system. The injection volume was 2 µL and the 
column and sample temperatures were 25 °C and 6 °C, respectively. AZA-1−3 were quantified 
relative to CRMs while AZA-4−10 were quantified with RMs [26]. Matrix interferences were 
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assessed using single point matrix matched standards for AZA-1−6 and AZA-8, using a blank M. 
edulis tissue. An aliquot (2 g) of tissue was extracted as described above, this time making the 
solution up to a final volume of 20 mL. The matrix-matched standard was prepared by adding 
1.25 mL of an AZA-1−6 and AZA-8 stock solution in MeOH to 1 mL of the filtered (Whatmann, 
0.2 µm, cellulose acetate filter) blank tissue extract. In parallel, a MeOH standard was prepared 
by adding 1.25 mL of the same AZA-1−6 and AZA-8 stock solution to 1  mL of MeOH. 
 
2.7. Data analysis 
Measurements were performed in triplicate for the colorimetric immunoassays and 
electrochemical immunosensors and in duplicate for LC-MS/MS analysis. The immunoassay 
calibration curves were fitted using a sigmoidal logistic four-parameter equation. Linear 
regression was used to evaluate the correlation between AZA-1 equivalent concentrations in 
naturally contaminated mussel samples determined with the colorimetric immunoassays or the 
electrochemical immunosensors and the values obtained from the LC-MS/MS analyses. To 
evaluate differences between approaches, data were first tested for normality. To compare 
values from two different groups, the paired 𝑡-test was used for normally distributed data sets, 
while Wilcoxon matched-pairs signed-ranks was used for non-normally distributed data. One-
way ANOVA was performed to compare the values obtained in the analysis of the mussel 
samples by the colorimetric immunoassays, electrochemical immunosensors and LC-MS/MS 
analysis. Differences were considered statistically significant at the 0.05 level. SigmaStat 3.1 was 
used for statistical analysis. 
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3. RESULTS AND DISCUSSION 
 
3.1. Colorimetric immunoassays 
Microtitre plates were coated with protein G or avidin by passive adsorption, taking advantage 
of the hydrophobic interactions and the electrostatic forces generated between the negatively 
charged proteins and the positively charged microplates in alkaline conditions. The anti-AZA PAb 
was then immobilised on the coated plates by means of the affinity of the protein G to the Fc 
region of the antibody or through the strong avidin–biotin interaction following antibody 
biotinylation (Fig. 1). Both bioaffinity interactions provided the stable immobilisation of the PAb, 
while retaining its biological activity. However, while the use of protein G favoured the optimum 
orientation of the antibody to achieve optimal antigen binding without requiring any chemical 
modification, the avidin–biotin interaction required biotin labelling of the primary amines of the 
PAb, typically distributed on the exterior of the entire antibody, which did not ensure the correct 
orientation of the antibody.  
a 
 
 
b 
  
  
 
Fig. 1. Schematic representation of the immunoassays and immunosensors configurations 
achieved by the anti-AZA PAb immobilisation based on (a) protein G or (b) avidin–biotin affinity 
interaction on (a) microtitre plate wells and (b) electrodes, as examples. 
PG
[Abs] = 620 nm
TMBred
TMBox
microtitre plate well
TMBred
TMBox
e- -0.2 V vs. Ag
electrode
PG
anti-AZA PAb
AZA
AZA–HRP
Protein G
Avidin
Biotin
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Checkerboard titrations and competitive immunoassays were performed to determine if the 
antibody immobilisation was successful and to establish the optimum PAb and AZA–HRP 
concentrations. The absorbance values obtained showed expected trends according to antibody 
and AZA–HRP tracer concentrations. Lower absorbance values were obtained when the 
antibody was immobilised through the avidin–biotin interaction. Increasing the amount of avidin 
on the plate did not improve the immobilisation yield of the biotinylated antibody. Nevertheless, 
the lower absorbance values achieved in this configuration are not unexpected taking into 
account the biotinylation yield, which may not reach 100%, the non-optimally oriented 
immobilisation of the PAb and/or the possibility of biotinylation and immobilisation of other 
molecules containing primary amines present in the antiserum. 
Both immobilisation strategies provided very low non-specific adsorption values of the AZA–
HRP. Calibration curves demonstrated competition of free AZA-1 with AZA–HRP for PAb binding. 
Calibration curves were background-corrected with respect to the controls with no AZA-HRP and 
fitted to the sigmoidal logistic four-parameter equation: 
𝑦 = 𝑦0 +
𝑎
1 + (
𝑥
𝑥0
)𝑏
 
where 𝑎 and 𝑦0 are the asymptotic maximum and minimum values, respectively, 𝑥0 is the 𝑥 
value at the inflection point and 𝑏 is the slope at the inflection point. Greater sensitivities were 
achieved with decreasing concentrations of antibody and tracer. Consequently, 1/40000 PAb 
and 1/1600 AZA–HRP dilutions were selected as a compromise between low antibody/tracer 
loading and sufficiently high absorbance values. Figure 2 shows the calibration curves for the 
optimised protein G and avidin-biotin interaction-based immunoassays. In table 1, limits of 
detection (LODs), established as the 10% inhibition coefficient (IC10) and working ranges 
(between IC20 and IC80) are presented together with the equations and the corresponding R2 
values. Differences between the two approaches were not significant (t=0.292, P=0.774). In 
comparison with the competitive colorimetric immunoassay previously reported by our group 
[25], where magnetic beads were used as antibody immobilisation supports, it was possible to 
use lower antiserum and tracer concentrations, which could explain the lower LODs achieved in 
these approaches. 
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Fig. 2. Colorimetric calibration curves for AZA-1 obtained using the protein G-based 
immunoassay (black) and the avidin–biotin interaction-based immunoassay (white) in buffer 
(circle) and in 20 mg/mL mussel matrix with 20% MeOH (triangle). 
 
Table 1. Analytical parameters derived from the sigmoidal logistic four-parameter fitting for the 
Protein G-based and avidin–biotin interaction-based colorimetric immunoassays and 
electrochemical immunosensors. 
  
LOD (IC10) 
(µg/L) 
Working range 
(IC20–IC80)  (µg/L) 
Equation R2 
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Protein G 0.28 0.70 – 22.74 
𝑦 = 2.052 +
99.494
1 + (
𝑥
3.468)
0.805
 
 
0.999 
Avidin–biotin 0.14 0.39 – 22.47 
𝑦 = 6.776 +
94.670
1 + (
𝑥
1.999)
0.751
 
 
1.000 
El
e
ct
ro
ch
e
m
ic
a
l 
im
m
u
n
o
se
n
so
rs
 
Protein G 0.61 1.25 – 56.81 
𝑦 = −10.073 +
132.192
1 + (
𝑥
5.413)
0.520
 
 
0.999 
Avidin–biotin 0.37 0.92 – 61.58 
𝑦 = −74.378 +
208.612
1 + (
𝑥
32.208)
0.295
 
 
0.999 
 
 
3.2. Study of matrix effects 
Prior to the analysis of mussel samples, AZA-1 calibration curves using a blank certified reference 
mussel tissue matrix (CRM-Zero-Mus) were performed to evaluate matrix effects on the 
immunoassays. A matrix concentration of 20 mg/mL mussel matrix was chosen according to the 
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protocol for lipophilic toxins extraction in shellfish (100 mg of matrix in 1 mL of MeOH) and its 
subsequent dilution to 20% v/v MeOH, a percentage that had been previously demonstrated 
not to interfere with the assay [25]. No significant differences were observed between the 
calibration curves performed in buffer and in 20 mg/mL mussel matrix with 20% v/v MeOH, 
neither in the protein G-based immunoassay (t=0.24, P=0.81) nor in the immunoassay based on 
the avidin–biotin interaction (t=0.32, P=0.77) (Fig. 2). Consequently, considering a 20 mg/mL 
matrix loading, effective LODs of 14 ± 1 µg AZA-1 equiv./kg and 7 ± 2 µg AZA-1 equiv./kg were 
achieved for the immunoassays developed by means of protein G and avidin–biotin 
immobilisation, respectively. Both immunoapproaches provided a broad working range, from 
35 ± 5 µg AZA-1 equiv./kg to 1137 ± 150 µg AZA-1 equiv./kg in the case of the protein G-based 
immunoassay and from 20 ± 3 µg AZA-1 equiv./kg to 1124 ± 118 in the case of the immunoassay 
based on the avidin–biotin interaction. Considering the EC regulatory limit for AZAs of 160 µg/kg, 
the immunoassays enabled the quantification of mussel samples from far below to far above 
the regulatory limit without requiring additional sample dilutions. 
 
3.3. Electrochemical immunosensors 
After protocol optimisation using the colorimetric immunoassays, both strategies were 
transferred to 8-electrode arrays to develop the corresponding electrochemical immunosensors 
(Fig. 1). Although reagent concentrations were the same as those selected in the colorimetric 
immunoassays, the use of lower volumes on the screen-printed electrodes required 5-fold lower 
amounts of protein G, avidin, anti-AZA PAb and tracer, which represents a substantial economic 
improvement. After background correction with respect to the controls with no AZA-HRP and 
fitting the calibration curves to the sigmoidal logistic four-parameter equation, Protein G and 
avidin–biotin interaction-based immunosensors provided similar analytical performances 
(t=0.10, P=0.92) (Table 1, Fig. 3). This work presents the first immunosensors for AZAs reported 
to date, providing user-friendly and compact tools that favour operation with low sample 
volumes and the performance of multiple measurements in a short time. 
Considering a 5-fold sample dilution to 20 mg/mL mussel matrix, as in the colorimetric assays, 
effective working ranges between 63 ± 3 and 2841 ± 247 µg AZA-1 equiv./kg for the protein G-
based immunosensor and between 46 ± 2 and 3079 ± 358 µg AZA-1 equiv./kg for the avidin–
biotin interaction-based immunosensor were calculated, again providing a broad working range 
that included the EC permitted threshold value. 
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Fig. 3. Electrochemical calibration curves for AZA-1 obtained using the protein G-based 
immunosensor (black) and the avidin–biotin interaction-based immunosensor (white) in buffer. 
 
3.4. Regeneration of the electrochemical immunosensors 
Electrochemical immunosensors are commonly developed using disposable screen-printed 
electrodes due to their low fabrication cost and the possibility of mass production. However, the 
lack of commercially available anti-AZA antibodies and the time-consuming antibody production 
process are clear limiting factors in the development of immunosensors for AZAs detection. The 
feasibility to reuse immunosensors presents expedient advantages regarding these limitations. 
With this purpose in mind, the possibility to remove the AZAs and the AZA–HRP bound to the 
PAb, once the competition assay had been performed, while retaining the PAb immobilisation 
on the electrode surface and its functionality was evaluated. 
Antibody-antigen interaction usually occurs at physiological pH and ionic strength, such as in 
PBS, and can be disrupted by simply raising or lowering the pH or altering the ionic state, ideally 
releasing the antibody or antigen without irreversibly denaturing or inactivating them. Thus, 
when immunosensors containing AZA–HRP were immersed in glycine buffer, pH 2.7, for 30 min, 
only background currents were observed after TMB incubation, indicative of complete AZA–HRP 
elution from the electrode. A subsequent incubation with AZA–HRP resulted in a response of 
~25% in the protein G-based functionalised electrodes, and a response of ~100% in the avidin–
biotin configuration. This 100% response demonstrates that the biotinylated antibody was 
retained on the avidin-coated electrode retaining its functionality, while the 25% response 
observed in the protein G approach suggests partial co-elution of the antibody during the elution 
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step in this specific configuration. Responses close to 100% following AZA-HRP incubation were 
maintained after the regeneration of the functionalised electrodes through the avidin–biotin 
interaction for 6 consecutive times on 3 different days (Fig. 4). These results demonstrate the 
reusability of the avidin–biotin interaction-based immunosensors and also highlight the storage 
stability of the immunosensors for at least 3 days. The possibility to reuse and store the 
immunosensors until use avoids the immobilisation of additional anti-AZA PAb amounts on the 
electrode surface, as well as simplifies and shortens the protocol assay. 
 
 
Fig. 4. Electrochemical responses of the avidin–biotin interaction-based immunosensors 
achieved after surface regeneration for 6 consecutive measurements (M#1–M#6) on 3 different 
days. 
 
3.5. AZAs detection in mussel samples 
To demonstrate the applicability of the electrochemical immunosensors as well as the 
colorimetric immunoassays to the determination of AZAs in shellfish, naturally contaminated 
mussel (M. edulis) samples were analysed using the different approaches.  
First, AZAs in a CRM containing AZA-1–3 (certified concentrations) and other analogues (AZA-4–
10) (non-certified concentrations) were determined by the protein G and avidin–biotin 
interaction-based colorimetric immunoassays and electrochemical immunosensors (Table 2). 
The immunoapproaches provided a global quantification relative to AZA-1, which was compared 
with the sum of all different analogues concentrations provided by the NRC. Correlations of 
153.4 % and 152.7 % were achieved between the quantifications provided by the protein G and 
avidin-biotin interaction-based colorimetric immunoassays, respectively, and NRC values. 
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Similar correlations were also obtained in the quantifications provided by the protein G (153.6 
%) and avidin-biotin (154.8 %) electrochemical immunosensors. These percentages higher than 
100% are not surprising taking into account the different recognition principles between 
analytical methods. While NRC values are obtained by physicochemical approaches, the 
immunoapproaches provide responses based on the structural recognition of the toxins by the 
antibody, which can differ between analogues and the assay configuration [25]. Consequently, 
the application of cross-reactivity factors (CRFs) to each individual AZA analogue concentration 
can contribute to better understand the correlation between the different analytical methods. 
Thus, CRFs that had been previously established in the magnetic bead-based immunoassay [25] 
–where the same PAb and a similar immunological approach were used– were applied to the 
individual AZA analogue concentrations provided by the NRC. Following the application of the 
corresponding CRFs to the certified values, correlations of 101.7% and 101.3% were achieved 
between the quantifications provided by the protein G and avidin–biotin interaction-based 
colorimetric immunoassays, respectively, and NRC values. Excellent correlations of 101.9 % and 
102.7 % were also obtained in the quantifications provided by the protein G and avidin–biotin 
electrochemical immunosensors. The obtained results suggest that the PAb recognise all AZA 
analogues with the same cross-reactivity as in the magnetic bead-based immunoassay and 
highlight the potential application of all the developed immunoapproaches to the determination 
of AZAs in mussel samples. 
In Ireland, AZAs have been detected in shellfish above the regulatory limit almost every year 
since the Irish monitoring program was established in 2001 [33]. Raw mussel samples (n=16) 
from this routine monitoring program containing a wide range of AZAs concentrations were 
selected for their quantification. From these 16 naturally contaminated samples, 11 had been 
previously analysed by the magnetic bead-based immunoassay [25]. Five additional mussel 
samples containing AZA-1, AZA-2 and AZA-3 levels below the established 160 µg/kg regulatory 
limit were included in the analysis to ensure that the developed immunoassays and 
immunosensors were able to provide reliable AZA quantifications at low concentrations (Table 
1). No differences were observed between the quantifications provided by the protein G and 
avidin-biotin interaction-based colorimetric immunoassays and electrochemical 
immunosensors (P=1.00), regardless of whether the values were below (P=0.851) or above 
(P=0.953) the regulatory level. Standard deviations lower than 10% were obtained for all 
samples using both approaches. 
Since the PAb used in the development of the immunoapproaches was able to recognise AZA 
carboxy cogeneres in addition to other AZA analogues, the raw mussel samples analysed were 
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heated to perform LC-MS/MS analysis. Heating catalyses the decarboxylation of AZA carboxy 
congeners (e.g., AZA-17, AZA-19, AZA-21 and AZA-23) that may be present in the samples to 
AZA-3, AZA-6, AZA-4 and AZA-9 respectively [31, 32]. AZA quantifications provided by the protein 
G-based colorimetric immunoassay (𝑦 = 1.489 𝑥 + 42, R2 = 0.981) and electrochemical 
immunosensor (𝑦 = 1.604 𝑥 + 7, R2 = 0.990) correlated with those obtained by LC-MS/MS 
analysis (p ˂ 0.0001). The immunoassay (𝑦 = 1.574 𝑥 + 18, R2 = 0.990) and the immunosensor 
(𝑦 = 1.582 𝑥 + 21, R2 = 0.977) developed through the avidin–biotin interaction also provided AZA 
quantifications in correlation with those achieved by the reference method (p ˂ 0.0001) (Table 
1, Figure 5). Without the application of the CRFs, the trend observed in the analysis of the mussel 
samples from the Irish monitoring program was similar to the trend obtained in the analysis of 
the CRM, being the quantifications achieved by the immunoapproaches ~1.5-fold those 
obtained with the reference method. Following the application of the corresponding CRFs to the 
individual contents determined by LC-MS/MS, AZA quantifications provided by the protein G-
based immunoassay (𝑦 = 0.965 𝑥 + 14, R2 = 0.999) and immunosensor (𝑦 = 1.035 𝑥 - 19, R2 = 
0.999) and the avidin–biotin interaction-based immunoassay (𝑦 = 1.016 𝑥 - 6, R2 = 0.998) and 
immunosensor (𝑦 = 1.029 𝑥 - 10, R2 = 0.999) were in excellent agreement with LC-MS/MS values 
(Table 2, Figure 5), with no significant differences observed between the quantifications 
achieved by any of the immunoapproaches and LC-MS/MS analysis (P = 1.000). 
All these results indicate without doubt that the developed immunoassays and immunosensors 
are reliable tools for the screening and quantification of AZAs, facilitating not only the detection 
of all the regulated AZAs below the regulatory limit, but also other toxic analogues in a simple, 
rapid and cost-effective manner. 
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Table 2. AZA concentrations (µg AZA/kg mussel) of a mussel certified reference material (CRM) and 16 naturally contaminated mussel tissues from the 
routine monitoring program in Ireland by LC-MS/MS, the colorimetric immunoassays and the electrochemical immunosensors. 
 
 
*Applied CRFs are: AZA-1 = 1; AZA-2 = 0.76; AZA-3 = 2.73; AZA-4 = 3.83; AZA-5 = 1.39; AZA-6 = 2.70; AZA-7 = 2.00; AZA-8 = 1.85; AZA-9 = 2.69; AZA-10 = 2.17 [25]. 
Samples 
LC-MS/MS Colorimetric immunoasays 
Electrochemical 
immunosensors 
AZA-
1 
AZA-
2 
AZA-
3 
AZA-
4 
AZA-
5 
AZA-
6 
AZA-
7 
AZA-
8 
AZA-
9 
AZA-
10 
∑ AZAs 
AZA-1 equiv. 
(∑ AZAs 
applying CRFs)* 
Protein G Avidin-biotin Protein G Avidin-biotin 
AZA-1 equiv. AZA-1 equiv. AZA-1 equiv. AZA-1 equiv. 
                 
CRM 1160 273 211 170 40 90 20 30 40 20 2054 3096 3150 3137 3155 3180 
                 
Monitoring                 
S#1 24 5 15 nd nd 3 nd nd nd nd 47 77 77 82 79 66 
S#2 22 8 15 nd nd 3 nd nd nd nd 48 77 79 73 80 76 
S#3 28 8 17 nd nd 2 nd nd nd nd 55 86 94 89 82 86 
S#4 21 8 23 nd nd 3 nd nd nd nd 55 98 95 97 113 65 
S#5 33 10 19 nd nd 2 nd nd nd nd 64 98 105 103 104 100 
S#6 49 19 31 nd 1 7 nd 2 nd nd 109 172 174 177 146 171 
S#7 55 19 29 1 1 4 nd nd nd nd 109 165 171 124 159 165 
S#8 53 20 31 1 2 4 nd nd nd nd 111 170 133 158 171 130 
S#9 128 45 66 3 4 10 nd 5 nd nd 261 396 412 394 376 414 
S#10 148 35 55 3 6 16 nd 1 1 3 268 399 381 391 398 404 
S#11 144 59 80 13 5 12 nd 6 1 2 322 515 523 535 513 475 
S#12 370 125 216 81 23 44 2 21 19 6 907 1623 1667 1534 1577 1646 
S#13 425 139 189 77 17 35 4 21 16 4 927 1558 1561 1582 1550 1676 
S#14 573 164 174 71 13 37 2 20 17 3 1074 1656 1631 1784 1661 1694 
S#15 798 258 480 142 32 101 2 46 32 7 1898 3356 3202 3301 3399 3488 
S#16 1524 414 309 132 33 64 10 49 38 9 2582 3639 3509 3778 3872 3664 
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Figure 5. Linear regressions for the correlations between sample quantifications by the 
colorimetric immunoassays or electrochemical immunosensors and the sum of AZA-1–10 
analogues determined by LC-MS/MS analysis, before (white) and after (black) the application of 
the cross-reactivity factors (CRFs). Dashed lines represent the prediction intervals of 95 %. 
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4. CONCLUSIONS 
The immobilisation of the anti-AZA PAb on protein G or avidin-coated supports via bioaffinity 
interactions has been used to develop immunoassays and immunosensors with excellent 
analytical performance, thanks to a controlled and stable antibody immobilisation. All 
approaches showed a broad working range that enabled the quantification of the current 
regulated AZAs below the regulatory threshold, but also a broad range of other toxic AZA 
analogues. No matrix effects were observed and no evaporation of the sample extracts was 
required, resulting in accurate quantifications with simple and rapid protocols. Although both 
colorimetric immunoassays and electrochemical immunosensors have been demonstrated to be 
powerful analytical methods for the reliable determination of AZAs, electrochemical 
immunosensors provide compact and miniaturised devices that pave the way towards the 
development of portable tools for in situ measurements. Moreover, the possibility to use lower 
amounts of immunoreagents, as well as the feasibility to reuse the avidin-biotin interaction-
based immunosensors provide clear advantages in terms of sustainability and cost-
effectiveness. 
The good results obtained in the analysis of a considerable amount of naturally contaminated 
mussel samples evidence that electrochemical immunosensors for the detection of AZAs can be 
effectively implemented as screening tools in routine monitoring programs, as they provide 
easy-to-handle, rapid and low-cost high-throughput systems for the specific detection of AZAs 
in complex matrices. For their practical application in current monitoring programs, it is 
important to keep in mind that the regulatory limit of 160 µg AZA-1 equivalents/kg shellfish 
established by the European Commission only considers AZA-1–3 (including their toxic 
potential). As a consequence, in samples where more than these three analogues are present, 
immunoapproaches could provide results that may lead to a closure of a shellfish harvesting 
area, while LC-MS/MS analysis could not. This fact is not detrimental for immunoapproaches, 
but helps to better protect consumer health. Taking this in mind, we propose to establish a 
“positive”, “negative” but also a “suspicious” range to classify samples according to their AZA 
content. In the case of a “positive” result, a preventive closure of the shellfish harvesting area 
will be recommended to protect the consumer health and the sample will be analysed by LC-
MS/MS to confirm the result. In the case of a “suspicious” sample, analysis by LC-MS/MS will 
help to determine the decision to undertake. By combining screening and confirmatory methods 
a faster and cost-effective system for marine toxin control in shellfish will be clearly achieved. 
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